Top

Published in:

01-12-2012 | Original Communication

IVIG treatment in post-polio patients: evaluation of responders

Authors: Gunilla Östlund, Lisbet Broman, Lars Werhagen, Kristian Borg

Published in: Journal of Neurology | Issue 12/2012

Abstract

The aim of this work is to evaluate the outcome of IVIG treatment in patients with post-polio syndrome (PPS) and to identify responders. The study included 113 PPS patients who had received one IVIG treatment in an open trial, prospective follow-up study. Clinical examination was performed and clinical data were retrieved from medical records. The short form 36 (SF-36), physical activity scale for the elderly (PASE), and the visual analogue scale (VAS) were used as measurements of quality of life, physical activity, and the intensity of pain. Data before treatment and at 6-month follow-up were collected. Analysis was performed in subgroups based on demographic and medical parameters. A statistically significant increase of the SF-36 sub domains bodily pain, vitality, social function, role emotional, and the mental compound score (MCS) was found at the 6-month follow-up. A significant decrease of pain was found in patients who reported pain intensity over VAS of 20 mm, in patients younger than 65 years of age and in patients who had paresis in the lower extremities. A trend was found in patients with PPS as the only diagnosis. IVIG leads to increase of quality of life at 6-month follow-up for SF-36 regarding sub domains of bodily pain, vitality, social function, role emotional, as well as for pain. Age below 65 years, paresis in the lower extremities, and lack of concomitant disorders may be the main indicators for a future identification of responders.

Melnick JL (1996) Current status of poliovirus infections. Clin Microbiol Rev 9:293–300PubMed

March of Dimes Post-polio syndrome: identifying best practice in diagnosis and care. http://www.marchofdimes.com/files/PPS report.pdf. Accessed April 30, 2010

Borg K (1996) Post-polio muscle dysfunction 29th ENMC workshop 14–16 October 1994, Naarden, The Netherlands. Neuromuscul Disord 6:75–80PubMedCrossRef

Trojan DA, Cashman NR (2005) Post-poliomyelitis syndrome. Muscle Nerve 31:6–19PubMedCrossRef

Farbu E, Gilhus NE, Barnes MP, Borg K, de Visser M, Driessen A, Howard R, Nollet F, Opara J, Stalberg E (2006) EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force. Eur J Neurol 13:795–801PubMedCrossRef

Gonzaelz H, Olsson T, Borg K (2010) Management of post-polio syndrome. Lancet 9:634–642CrossRef

Gonzalez H, Khademi M, Andersson M, Wallström E, Borg K, Olsson T (2002) Prior poliomyelitis—evidence of cytokine production in the central nervous system. J Neurol Sci 205:9–13PubMedCrossRef

Gonzalez H, Khademi M, Andersson M, Piehl F, Wallström E, Borg K, Olsson T (2004) Prior poliomyelitis—IVIG treatment reduces proinflammatory cytokine production. J Neuroimmunol 150:139–144PubMedCrossRef

Farbu E, Rekand T, Vik-Mo E, Lygren H, Gilhus NE, Aarli JA (2007) Post-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study. Eur J Neurol 14:60–65PubMedCrossRef

10.

Fordyce CB, Gagne D, Jalili F, Alatab S, Arnold DL, Da Costa D, Sawoszczuk S, Bodner C, Shapiro S, Collet J-P, Robinson A, Le Cruguel J-P, Lapierre Y, Bar-Or A, Trojan DA (2008) Elevated serum inflammatory markers in post-poliomyelitis syndrome. J Neurol Sci 271:80–86PubMedCrossRef

11.

Gonzalez H, Ottervald J, Nilsson KC, Sjögren N, Miliotis T, Von Bahr H, Khademi M, Eriksson B, Kjellström S, Vegvari A, Harris R, Marko-Varga G, Borg K, Nilsson J, Laurell T, Olsson T, Franzén B (2009) Identification of novel candidate protein biomarkers for the post-polio syndrome—implication for diagnosis, neurodegeneration and neuroinflammation. J Proteomics 71:670–681PubMedCrossRef

12.

Koopman FS, Uegaki K, Gilhus NE, Beelen A, de Visser M, Nollet F (2011) Treatment for post-polio (Review). The Cochrane Library, Issue 4

13.

Gonzalez H, Stibrant-Sunnerhagen K, Sjöberg I, Kapanoides G, Olsson T, Borg K (2006) Intravenous immunoglobulin for post-polio syndrome: a randomised controlled trial. Lancet Neurol 5:493–500PubMedCrossRef

14.

Kaponides G, Gonzalez H, Olsson H, Borg K (2006) Effect of intravenous immunoglobulin in patients with post-polio syndrome—an uncontrolled pilot study. J Rehabil Med 38:138–140PubMedCrossRef

15.

Werhagen L, Borg K (2011) Effect of intravenous immunoglobulin on pain with post-polio syndrome. J Rehabil Med 43:1038–1040PubMedCrossRef

16.

Sullivan M, Karlsson J, Ware JR (1995) The Swedish SF-36 Health Survey-I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med 41:1349–1358PubMedCrossRef

17.

Sullivan M, Karlsson J (1998) The Swedish SF-36 Health Survey III. Evaluation of criterion-based validity: results from normative population. J Clin Epidemiol 51:1105–1113PubMedCrossRef

18.

Ware JE, Snow KK, Kosinski M, Gandek B (1993) SF36 Health Survey Manual and Interpretation Guide. New England Medical Center, The Health Institute, Boston

19.

Washburn, McAuley, Katula, Mihalko, Boileau (1999) PASE. Physical activity scale for the elderly. Administration and scoring instruction manual 1991. New England Research Institute, Watertown

20.

Washburn RA, McAuley E, Katula J, Mihalko SL, Boileau RA (1999) The physical activity for the elderly (PASE): evidence for validity. J Clin Epidemiol 52:643–651PubMedCrossRef

21.

PASE. Physical activity scale for the elderly (1991) Administration and scoring instruction manual. New England Research Institute, Watertown

22.

Huskisson EC (1974) Measurement of pain. Lancet 2:1127–1131PubMedCrossRef

23.

Joyce CR, Zutshi DW (1975) Comparison of fixed interval and visual analogue scales for rating chronic pain. Eur J Clin Pharmacol 8:415–420PubMedCrossRef

24.

Jensen MP, Alschuler KN, Smith AE, Verrall AM, Goetz MC, Molton IR (2011) Pain and fatigue in persons with postpolio syndrome: independent effects on functioning. ArchPhys Med Rehabil 92:1796–1801CrossRef

25.

Price DD, Finniss DG, Benedetti F (2008) A comprehensive review of the placebo effect: recent advantages and current thought. Annu Rev Psychol 59:565–590PubMedCrossRef

Title: IVIG treatment in post-polio patients: evaluation of responders
Authors: Gunilla Östlund
Lisbet Broman
Lars Werhagen
Kristian Borg
Publication date: 01-12-2012
Publisher: Springer-Verlag
Published in: Journal of Neurology / Issue 12/2012
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-012-6538-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

IVIG treatment in post-polio patients: evaluation of responders

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 12/2012

A case of multiple system atrophy with normal dopamine transporter imaging

Codon 200 mutation of the prion gene: genotype–phenotype correlations

Auditory pathway changes mirror overall disease progress in individuals with Friedreich ataxia

The progression of non-motor symptoms in Parkinson’s disease and their contribution to motor disability and quality of life

Severe underweight and cerebral microbleeds

Paraneoplastic encephalitis presenting as pure word deafness in a patient with small cell lung cancer